Home Compare MRK vs ROG.SW
Stock Comparison · Industry comparison · Drug Manufacturers - General

Merck & Co. vs Roche Holding: Which Stock Looks Stronger in 2026?

Structurally, Merck and Roche are closely matched — neither holds a meaningful edge overall. Roche still leads on growth and profitability, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The page question resolves more clearly through growth, even though the overall score is effectively tied.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. MRK and ROG.SW share the same industry classification.

For a similarity-based comparison, see how Merck and Roche each position within their functional peer groups in AssetNext.

Peer-Relative Score
MRK
Merck & Co., Inc.
63
Peer-Score
Signal qualityHigh
vs
ROG.SW
Roche Holding AG
63
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: MRK vs ROG.SW Profitability 62 75 Stability 57 51 Valuation 88 64 Growth 31 55 MRK ROG.SW
Gap Ranking
#1 Growth +24
#2 Valuation +24
#3 Profitability +13
#4 Stability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MRK and ROG.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MRKROG.SW Relative valuation Structural strength

Roche Holding AG occupies the cheaper side of the setup map, although Merck & Co., Inc. still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Roche Holding AG sits in the stronger part of the group on growth, while Merck & Co., Inc. is closer to mid-pack.
Valuation
Both rank well on valuation, but Merck & Co., Inc. still holds a clear edge.
Growth — Dominant Gap
MRK
31
ROG.SW
55
Gap+24in favour of ROG.SW

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

Capital efficiency also runs the other way, with a 9.7-point ROIC edge acting as a real counterforce.

What this means for the comparison

Growth is the clearest driver of the lead, with valuation adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the MRK vs ROG.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how MRK and ROG.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.